ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 25 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $20,140,000 | -9.1% | 18,779,000 | 0.0% | 2.44% | -2.6% |
Q2 2019 | $22,147,000 | +7.4% | 18,779,000 | 0.0% | 2.50% | -9.2% |
Q1 2019 | $20,614,000 | +9.4% | 18,779,000 | 0.0% | 2.76% | +9.8% |
Q4 2018 | $18,849,000 | -5.3% | 18,779,000 | 0.0% | 2.51% | +100.2% |
Q3 2018 | $19,906,000 | -7.2% | 18,779,000 | +99900.0% | 1.25% | -9.2% |
Q2 2018 | $21,455,000 | +3.7% | 18,779 | 0.0% | 1.38% | +2.4% |
Q1 2018 | $20,692,000 | -3.9% | 18,779 | 0.0% | 1.35% | -53.6% |
Q4 2017 | $21,537,000 | +6.0% | 18,779 | 0.0% | 2.90% | -16.5% |
Q3 2017 | $20,315,000 | +2.5% | 18,779 | 0.0% | 3.48% | -13.9% |
Q2 2017 | $19,817,000 | +300.7% | 18,779 | +302.1% | 4.04% | +257.3% |
Q1 2017 | $4,946,000 | – | 4,670 | – | 1.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 9,000,000 | $10,149,000 | 12.63% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 29,751,000 | $33,847,000 | 2.02% |
Wellesley Asset Management | 25,925 | $29,366,000 | 1.76% |
MANGROVE PARTNERS IM, LLC | 18,779 | $21,455,000 | 1.38% |
Perceptive Advisors | 7,500,000 | $8,458,000 | 0.22% |
OAKTREE CAPITAL MANAGEMENT LP | 6,857,000 | $7,767,000 | 0.11% |
WOLVERINE ASSET MANAGEMENT LLC | 5,975,000 | $6,769,000 | 0.09% |
PALISADE CAPITAL MANAGEMENT, LP | 1,718,000 | $1,945,000 | 0.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 930,000 | $1,049,000 | 0.03% |
GABELLI FUNDS LLC | 1,750,000 | $1,983,000 | 0.01% |